Table 2. Country-specific estimates of historical smallpox vaccine effectiveness (VE) against mpox, Denmark, the Netherlands, France and Spain, March–July 2022.
Country | Birth cohorta | Number of cases with vaccination information | Proportion of the population vaccinated | Number of cases vaccinated | Proportion of vaccinated cases (%) | VE (95% CI) |
---|---|---|---|---|---|---|
Denmark | Born up to and including 1966 | 5 | 95% | 5 | 100 | NA (NA–100) |
France | Born up to and including 1965 | 74 | 90% | 54 | 73 | 70% (50–82) |
The Netherlands | Born up to and including 1970 | 97 | 89% | 80 | 82 | 42% (2–66) |
Spain | Born up to and including 1969 | 131 | 90% | 78 | 60 | 84% (77–88) |
CI: confidence interval; NA: not ascertainable; VE: vaccine effectiveness.
a Birth cohorts from before the smallpox vaccination programme was phased out in each country.